A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial
暂无分享,去创建一个
D. Dodick | M. Ashina | R. Lenz | M. Lanteri-Minet | D. Kudrow | V. Osipova | D. Mikol | H. Picard | Kerry Palmer